Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
You may also like
Gainers
Latest Crypto News
Bastion announces providing Sony Bank with stablecoin issuance, reserve management, and custody services
The UK government is considering banning cryptocurrency for political donations to avoid foreign interference
Federal Reserve Governor Bowman: Seeking to Establish New Rules for Banks and Stablecoins to Ensure Fair Competition
Sahara Official Denies "Token's Sharp Decline Due to Market Maker Liquidation"
Unlimit Launches Stablecoin Decentralized Clearing Platform Stable.com
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]